Skip to main content
. 2023 Jan 24;18(1):e0280456. doi: 10.1371/journal.pone.0280456

Table 1. Dosimetric comparison between VMT-5B and VMAT-10B for the targets.

Parameters VMAT-5B VMAT-10B P value
PTV
V95% (%) 99.59 ± 0.33 99.58 ± 0.34 0.799
D95% (Gy) 49.9 ± 0.22 50.07 ± 0.10 0.074
D98% (Gy) 49.0 ± 0.35 49.00 ± 0.32 0.445
Dmean (Gy) 52.10 ± 0.28 52.13 ± 0.36 0.878
D2% (Gy) 54.20 ± 0.43 53.78 ± 0.46 <0.001
V110% (%) 0.39 ± 0.59 0.06 ± 0.12 0.005 *
HI 0.10 ± 0.01 0.09 ± 0.01 <0.001
CTV
V95% (%) 99.90 ± 0.04 99.98 ± 0.03 0.028 *
D95% (Gy) 50.70 ± 0.35 51.23 ± 0.35 <0.001
D98% (Gy) 50.30 ± 0.37 50.87 ± 0.35 <0.001
Dmean (Gy) 52.30 ± 0.31 52.43 ± 0.41 0.391
D2% (Gy) 54.30 ± 0.45 53.80 ± 0.46 <0.001
V110% (%) 0.47 ± 0.66 0.04 ± 0.08 0.005 *
HI 0.08 ± 0.01 0.06 ± 0.01 <0.001

The values in bold indicate significant differences.

*Significant differences with paired Wilcoxon signed-rank test.